Skip to content
Home/Companies/Biotech/Ternary Therapeutics

Ternary Therapeutics

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Ternary Therapeutics?

Ternary Therapeutics is currently owned by Daphni through Daphni Blue (2025 vintage), since 2025.

Hand-verified · updated 2026-08-11

Daphni
Investor
Daphni
Daphni Blue · 2025 · VC

Key facts

HQFrance
SectorBiotech
StatusActive

More from Daphni Blue

Other portfolio companies in the same fund.

AMI Labs
Active
AI/MLFrance· 2026
Astral Systems
Active
EnergyUK· 2026
baCta
baCta
Active
BiotechFrance· 2026
Certo
Active
AI/MLFrance· 2026
Generare
Active
BiotechFrance· 2026
GraphTx
Active
BiotechFrance· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Ternary Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Ternary Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue